Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis

Arthritis Rheum. 2007 Jun;56(6):2094-6. doi: 10.1002/art.22666.
No abstract available

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / ethnology
  • Female
  • Humans
  • Isoxazoles / adverse effects*
  • Isoxazoles / therapeutic use
  • Korea
  • Leflunomide
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / ethnology
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • Antirheumatic Agents
  • Isoxazoles
  • Leflunomide